BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26010339)

  • 1. Urine testing for antipsychotics: a pilot trial for a method to determine detection levels.
    Miller J; Wehring H; McMahon RP; DiPaula BA; Love RC; Morris AA; Raley H; Feldman S; Kelly DL
    Hum Psychopharmacol; 2015 Sep; 30(5):350-5. PubMed ID: 26010339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Nonmodifiable Patient Factors on Antipsychotic Medication use in the Intensive Care Unit.
    Connell J; McCann B; Feng X; Shotwell MS; Hughes CG; Boncyk CS
    J Intensive Care Med; 2024 Feb; 39(2):176-182. PubMed ID: 37644873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis.
    Zhou X; Keitner GI; Qin B; Ravindran AV; Bauer M; Del Giovane C; Zhao J; Liu Y; Fang Y; Zhang Y; Xie P
    Int J Neuropsychopharmacol; 2015 May; 18(11):pyv060. PubMed ID: 26012350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine and risperidone plasma concentration therapeutic drug monitoring: A feasibility study.
    Law S; Gudbrandsen M; Magill N; Sweetman I; Rose D; Landau S; Flanagan RJ; David AS; Patel MX
    J Psychopharmacol; 2015 Aug; 29(8):933-42. PubMed ID: 26040903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.
    Stentebjerg-Olesen M; Ganocy SJ; Findling RL; Chang K; DelBello MP; Kane JM; Tohen M; Jeppesen P; Correll CU
    Eur Child Adolesc Psychiatry; 2015 Dec; 24(12):1485-96. PubMed ID: 26032132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.
    Stinton C; McKeith I; Taylor JP; Lafortune L; Mioshi E; Mak E; Cambridge V; Mason J; Thomas A; O'Brien JT
    Am J Psychiatry; 2015 Aug; 172(8):731-42. PubMed ID: 26085043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of antidepressants and antipsychotics on weight gain in children and adolescents.
    Reekie J; Hosking SP; Prakash C; Kao KT; Juonala M; Sabin MA
    Obes Rev; 2015 Jul; 16(7):566-80. PubMed ID: 26016407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.
    Subotnik KL; Casaus LR; Ventura J; Luo JS; Hellemann GS; Gretchen-Doorly D; Marder S; Nuechterlein KH
    JAMA Psychiatry; 2015 Aug; 72(8):822-9. PubMed ID: 26107752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder.
    Dominick K; Wink LK; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):397-401. PubMed ID: 26091194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.
    Carton L; Cottencin O; Lapeyre-Mestre M; Geoffroy PA; Favre J; Simon N; Bordet R; Rolland B
    Curr Pharm Des; 2015; 21(23):3280-97. PubMed ID: 26088115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Use of Second-Generation Antipsychotics for the Treatment of ICU Delirium.
    Mo Y; Yam FK
    J Pharm Pract; 2017 Feb; 30(1):121-129. PubMed ID: 26033792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels.
    Hefner G; Shams ME; Unterecker S; Falter T; Hiemke C
    Psychopharmacology (Berl); 2016 May; 233(9):1695-705. PubMed ID: 26032842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: a focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization.
    Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Kotowsky N; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
    Schizophr Res; 2015 Aug; 166(1-3):69-79. PubMed ID: 26027848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
    Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
    Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants.
    Himmerich H; Minkwitz J; Kirkby KC
    Endocr Metab Immune Disord Drug Targets; 2015; 15(4):252-60. PubMed ID: 26100432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
    Mohamed S; Rosenheck RA; Lin H; Swartz M; McEvoy J; Stroup S
    J Nerv Ment Dis; 2015 Jul; 203(7):486-92. PubMed ID: 26075840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early antipsychotic intervention and schizophrenia.
    Yang YY; Lu CL; Lo SM; Peng CH; Liu YP
    Med Hypotheses; 2015 Sep; 85(3):367-70. PubMed ID: 26048359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy.
    Marek GJ
    Curr Pharm Des; 2015; 21(26):3788-96. PubMed ID: 26044978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and Chronic Treatments with Quetiapine Increase Mitochondrial Respiratory Chain Complex Activity in the Rat Brain.
    Ignácio ZM; Réus GZ; Abelaira HM; Titus SE; Carlessi AS; da Luz JR; Matias BI; Bruchchen L; Carvalho-Silva M; Gomes LM; Rebelo J; Streck EL; Quevedo J
    Curr Neurovasc Res; 2015; 12(3):283-92. PubMed ID: 26036973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the effect of risperidone on speech: A cross-sectional study.
    Sinha P; Vandana VP; Lewis NV; Jayaram M; Enderby P
    Asian J Psychiatr; 2015 Jun; 15():51-5. PubMed ID: 26013669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.